IPM Take
This is a progress story, but not a victory story. The world has cut deaths from enteric infections dramatically, helped by vaccines, oral rehydration, cleaner water, sanitation and broader development. But the remaining burden is concentrated where systems are least able to absorb it. A child dying from diarrhoeal disease in 2026 is not dying because the world lacks tools. They are dying because the tools do not reach them reliably enough.
Executive Summary
A Lancet Infectious Diseases analysis from the Global Burden of Disease Study 2023 found that global deaths from enteric infectious diseases fell from 3.69 million in 1990 to 1.27 million in 2023. Diarrhoeal diseases accounted for most deaths in 2023, at 1.11 million. CIDRAP’s 12 June report highlighted that 317,000 children under five still died from diarrhoeal disease in 2023, with more than 70% of those child deaths in sub-Saharan Africa.
Why it matters
- Policymakers: Need sustained investment in rotavirus vaccination, oral rehydration salts, zinc, clean water and sanitation.
- Public authorities: Should focus on regions still missing child mortality targets for diarrhoeal disease.
- Patients / families: Survival depends on basic tools reaching children early enough: safe water, hydration, vaccination and rapid care.
The global picture is better than it was. It is still not good enough.
Deaths from enteric infectious diseases have fallen sharply since 1990. That is real progress. It reflects overlapping gains: rotavirus vaccination, oral rehydration, cleaner water, safer sanitation and better access to care. These are not glamorous interventions, but they have saved millions of lives.
Yet the remaining burden is brutal. In 2023, an estimated 317,000 children under five still died from diarrhoeal disease. More than 70% of those deaths were in sub-Saharan Africa. More than a quarter of countries and territories still failed to meet the global target for diarrhoeal disease deaths in children under five.
This is where the politics sits. Global health can celebrate progress while still underfunding the systems that would finish the job. Financing cuts, climate pressure, weak WASH infrastructure and drug-resistant enteric bacteria all threaten the gains already made.
For IPM, this is not only an infectious disease story. It is an implementation story. Precision public health does not always mean a new molecular test or advanced therapy. Sometimes it means knowing exactly where children are still dying and getting the oldest, simplest, most effective tools to them before dehydration becomes fatal.
